OncoImmunology
Volume 8, 2019 - Issue 3
Open access
3,071
Views
46
CrossRef citations to date
0
Altmetric
Original Research
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy
Amélie BoichardDepartment of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, University of California, Moores Cancer Center, La Jolla, CA, USA
https://orcid.org/0000-0001-5437-5770View further author information
Timothy V. PhamCureMatch Inc., San Diego, CA, USAView further author information
, Huwate YeernaDepartment of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, University of California, Moores Cancer Center, La Jolla, CA, USAView further author information
, Aaron GoodmanDepartment of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, University of California, Moores Cancer Center, La Jolla, CA, USA;Division of Blood and Marrow Transplantation, University of California, Moores Cancer Center, La Jolla, CA, USAView further author information
, Pablo TamayoDepartment of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, University of California, Moores Cancer Center, La Jolla, CA, USA;Division of Medical Genetics, University of California San Diego School of Medicine, La Jolla, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-9360-4668View further author information
Scott LippmanDepartment of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, University of California, Moores Cancer Center, La Jolla, CA, USAView further author information
, Garrett M. FramptonFoundation Medicine, Inc., Cambridge, MA, USAView further author information
, Igor F. TsigelnyCureMatch Inc., San Diego, CA, USA;San Diego Supercomputer Center and Neuroscience Department, University of California San Diego, La Jolla, CA, USA
https://orcid.org/0000-0002-7155-8947View further author information
Razelle KurzrockDepartment of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, University of California, Moores Cancer Center, La Jolla, CA, USA
https://orcid.org/0000-0003-4110-1214View further author information
Article: 1550341
|
Received 05 Jun 2018, Accepted 10 Nov 2018, Published online: 24 Dec 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.